ProPhase Labs, Inc.
PRPH
$0.416
$0.00852.09%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -79.66% | -77.12% | -69.59% | -63.81% | -57.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -79.66% | -77.12% | -69.59% | -63.81% | -57.04% |
| Cost of Revenue | -47.45% | -48.82% | -44.11% | -45.87% | -48.17% |
| Gross Profit | -113.51% | -104.07% | -89.93% | -77.02% | -63.59% |
| SG&A Expenses | -22.30% | -19.27% | -3.04% | 0.34% | 33.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.29% | -39.24% | -30.89% | -33.37% | -24.67% |
| Operating Income | -130.70% | -390.68% | -469.80% | -191.60% | -136.24% |
| Income Before Tax | -132.98% | -360.20% | -525.69% | -199.52% | -143.28% |
| Income Tax Expenses | -75.67% | -177.12% | -924.35% | -235.39% | -194.01% |
| Earnings from Continuing Operations | -164.97% | -502.61% | -461.92% | -190.89% | -133.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.97% | -502.61% | -461.92% | -190.89% | -133.26% |
| EBIT | -130.70% | -390.68% | -469.80% | -191.60% | -136.24% |
| EBITDA | -179.07% | -1,199.37% | -284.28% | -154.16% | -121.10% |
| EPS Basic | -141.93% | -458.24% | -417.05% | -179.94% | -130.63% |
| Normalized Basic EPS | -116.69% | -345.78% | -453.15% | -186.11% | -135.39% |
| EPS Diluted | -144.92% | -457.47% | -500.36% | -198.16% | -140.31% |
| Normalized Diluted EPS | -116.15% | -320.76% | -604.25% | -210.46% | -148.70% |
| Average Basic Shares Outstanding | 10.53% | 9.78% | 8.77% | 8.89% | 7.25% |
| Average Diluted Shares Outstanding | 8.41% | 1.07% | -5.02% | -5.86% | -21.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -1.12% |
